Skip to content
Review Open access

Prediction Models for Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis

Oct 2026 · Cancers · Vol 18 · 0 citations · 56 references
Medicine

TL;DR

These findings should be interpreted cautiously because area under the receiver operating characteristic curve (AUC) alone does not establish clinical utility, and Prospective, multicentre validation studies reporting sensitivity, specificity, predictive values, likelihood ratios, calibration, and decision curve analyses are urgently needed.

Abstract

Simple Summary Accurately predicting which patients with locally advanced rectal cancer (LARC) will achieve a pathological complete response (pCR) after preoperative chemoradiotherapy may help risk stratification and trial design. However, pCR is a postoperative pathological endpoint, whereas organ-preserving “watch-and-wait” decisions depend on clinical complete response (cCR). These endpoints are not interchangeable. We conducted a systematic review and meta-analysis of 43 studies covering 67,302 patients. Pooled estimates were numerically highest for deep learning models, followed by magnetic resonance imaging (MRI) radiomics, combined approaches, gene expression signatures, and clinical factors alone. However, between-study heterogeneity was substantial, publication bias was evident, and external validation performance was lower than internal validation performance. These findings should be interpreted cautiously because area under the receiver operating characteristic curve (AUC) alone does not establish clinical utility. Prospective, multicentre validation studies reporting sensitivity, specificity, predictive values, likelihood ratios, calibration, and decision curve analyses are urgently needed.

Read PDF

Similar papers

Open access Oct 2026

Predicting Pathologic Complete Response in Breast Cancer Using Pre-Treatment DCE-MRI

Prediction of pathological complete response (pCR) in breast cancer is relevant for clinical decision making and individual risk assessment, but remains challenging at present. This study aimed to design and validate clinically-informed, interpretable dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) frame...

B. Prathibha, Rashmi P. Karchi · 0 citations
Open access Oct 2026

Pathological Response Depth and Pre-Treatment Risk Stratification After Neoadjuvant Chemoradiotherapy for Rectal Cancer

NCRT exposure was not statistically associated with the evaluated short-term outcomes, which does not establish equivalence between strategies; depth of pathological response and host comorbidity carried the prognostic information, and routine pre-treatment variables showed promise for anticipating poor response.

Tibiana Negru, L. Stana, L. Stânga et al. · 0 citations
Open access Oct 2026

Prediction of Pathological Complete Response to Neoadjuvant Immunotherapy-Based Regimens for Non-Metastatic Colon and Rectal Cancer

Background: Pathological complete response (pCR) after neoadjuvant immunotherapy is associated with improved prognosis in colon and rectal cancer. This study aimed to develop and validate a predictive nomogram for pCR in CRC patients receiving neoadjuvant immunotherapy. Methods: A total of 232 eligible CRC patients who...

Xiao-Yan Huang, Mei-Ling Ye, Zhi-Kun Liang et al. · 0 citations
Open access Oct 2026

Comparison of neoadjuvant treatment strategies in resectable locally advanced esophageal squamous cell carcinoma: A real-world study

In this retrospective real-world cohort, pCR and toxicity profiles differed among the three neoadjuvant strategies, whereas no statistically significant differences in PFS or OS were detected after overlap weighting.

Xiao-Han Wang, Jing-Jing Liu, Jie Cui et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.